Strande, Jennifer L <br/><br/>
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.  [electronic resource] 

 -  Basic research in cardiology  Jul 2007 
 - 350-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0300-8428 
<br/><br/><label>Standard No.: </label>10.1007/s00395-007-0653-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Animals<br/>Cardiotonic Agents--pharmacology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--pharmacology<br/>Glyburide--pharmacology<br/>Hirudins--pharmacology<br/>Male<br/>Myocardial Infarction--genetics<br/>Myocardial Reperfusion Injury--genetics<br/>Myocardium--metabolism<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Oligopeptides--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Potassium Channel Blockers--pharmacology<br/>Potassium Channels--metabolism<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Pyrroles--pharmacology<br/>Quinazolines--pharmacology<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, PAR-1--genetics<br/>Recombinant Proteins--pharmacology<br/>Research Design<br/>Signal Transduction--drug effects<br/>Thrombin--antagonists & inhibitors<br/>Time Factors<br/>Ventricular Function, Left--drug effects<br/>Wortmannin<br/>omega-N-Methylarginine--pharmacology<br/>Platelet Aggregation Inhibitors